In this episode of Life Science Lab, host Christopher Conway sits down with Victoria Cogger, PhD, founding Executive Director of the Sydney Biomedical Accelerator (SBA), a landmark partnership between the University of Sydney, Sydney Local Health District, and the NSW government. Set to open in 2028, the SBA is envisioned as a world-leading health, education, and biomedical research complex.
They discuss the biomedical research and funding landscape in Australia, the origins of SBA, and how it aims to close the gap between discovery research and clinical impact. Dr. Cogger also shares her perspective on industry and philanthropic investment in life sciences, as well as the promise and caution surrounding AI's growing role in drug discovery.
About Indiana Biosciences Research Institute
Indiana Biosciences Research Institute (IBRI) is a first-in-class translational medicine institute dedicated to advancing life sciences in the race to eliminate disease and improve human health and life. By connecting early-stage biotech companies with cutting-edge life science discoveries —and backed by the mission and resources of industry leaders, investors, and philanthropic partners— IBRI is successfully evolving a new, independent model to conquer disease, uniting previously fragmented forces in the quest for cures.
Learn more about IBRI here: https://www.indianabiosciences.org/
More episodes from "Life Science Lab"
Don't miss an episode of “Life Science Lab” and subscribe to it in the GetPodcast app.
